《中国康复理论与实践》

《中国康复理论与实践》 ›› 2004, Vol. 10 ›› Issue (05): 304-305.

• 临床研究 • 上一篇    下一篇

脑血疏口服液治疗高血压性脑出血的对照研究

鲁明1; 谢汝萍1; 付瑜1; 谢道珍2   

  1. 1.北京大学第三医院神经科 北京市 100083;2.中国中医研究院西苑医院神经科 北京市 100086
  • 收稿日期:2004-02-12 出版日期:2004-05-25 发布日期:2004-05-25

Effect of Naoxueshu oral liquid on cerebral hemorrhage caused by hypertension

LU Ming, XIE Ru-ping, FU Yu,et al   

  1. Department of Neurology, the Third Hospital, Peking University, Beijing 100083, China
  • Received:2004-02-12 Published:2004-05-25 Online:2004-05-25

PDF (PC)

摘要： 目的研究脑血疏口服液治疗高血压性脑出血的临床疗效。方法将脑出血患者随机分为治疗组和对照组各70例。治疗组给予脑血疏口服液,对照组给予脑血康口服液,共观察1个月。治疗前后分别评测中医证候积分、美国国立健康研究院(NIH)卒中量表积分和颅内出血量的变化。结果治疗前后治疗组NIH积分减少(12.73±3.94),显著优于对照组的(4.72± 3.01,t=13.5327,P<0.001);颅内出血量治疗组减少(13.28±4.17)ml,显著优于对照组的(8.37±7.24)ml(t=4.9228,P<0.001)。治疗组总有效率95 .7%,对照组为80%。结论与脑血康相比,脑血疏在促进血肿吸收,改善患者神经功能缺损程度方面,具有更好的效果。

关键词: 脑血疏口服液, 脑出血, 脑血康口服液

Abstract: ObjectiveTo investigate the effect of Naoxueshu oral liquid on cerebral hemorrhage caused by hypertension. Methods140 patients with cerebral hemorrhage were randomly dividied into two groups with a 1∶1 ratio,treatment group and control group. Patients in treatment group received Naoxueshu oral liquid 30 ml daily,while that in control received Naoxuekang oral liquid 30 ml daily. The changes of score on Chinese medical integration,National Institutes of Health (NIH) Stroke scale and the volume of intracranial hemorrhage were evaluated before and a month after treatment.ResultsThe decrease of NIH score of patients in treatment group was (12.73±3.94),but(4.72±3.01) with the control's (t=13.5327,P<0.001). The decrease of the volume of intracranial hemorrhage of patients in treatment group was (13.28±4.17) ml,but (8.37±7.24) ml with the control's(t=4.9228,P<0.001). ConclusionComparing with Naoxuekang,Naoxueshu can accelerate absorption of hematome and ameliorate the recovery of neurological disability more efficiently.

Key words: Naoxueshu oral liquid, cerebral hemorrhage, Naoxuekang oral liquid